CORT Financial Facts

Loss from operations: -10.03M
Basic and diluted net loss per share: -0.11
See Full Income Statement

Total stockholders' equity: 21.02M
Property and equipment , net of accumulated depreciation: 203K
See Full Balance Sheet

Corcept Therapeutics (CORT) Earnings

  |   Expand Research on CORT
Next EPS Date 5/5/14 *Est. EPS Growth Rate -22.2% *Last Qtr.
Average EPS % Beat Rate +5.3% Revenue Growth Rate +197.1% *Last Qtr.
Average % Move 1-Wk after EPS -2.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
11/7/13 Q313 -$0.08-$0.12 +$0.04$2.6M$2.7M N/A +139.4% Details
8/8/13 Q213 -$0.10-$0.11 +$0.01$1.9M$2.72M N/A +102.6% Details
8/7/12 Q212 -$0.09-$0.11 +$0.02N/AN/A N/A +13.3% Details
5/3/12 Q112 -$0.13-$0.11 -$0.02N/AN/A N/A +6.4% Details
11/10/10 Q310 -$0.10-$0.10 $0.00N/AN/A N/A +6.1% Details
3/5/14 Q413 -$0.11-$0.10 -$0.01$4.1M$4.01M N/A -1.8% Details
3/9/11 Q410 -$0.10-$0.10 $0.00N/A$120K N/A -3% Details
11/7/11 Q311 -$0.08-$0.10 +$0.02N/AN/A N/A +21.2% Details